Terms: = Pancreatic cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4 AND Diagnosis
3 results:
1. Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies.
Mogal MR; Jame JA; Sohel M; Mozibullah M; Mahmod MR; Junayed A; Kar N; Arbia L; Al Mamun A; Sikder MA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2059. PubMed ID: 38639039
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation.
Javanshir HT; Malekraeisi MA; Ebrahimi SSS; Bereimipour A; Kashani SF; Bostaki AA; Mahmoodzadeh H; Nayernia K
J Med Life; 2022 Sep; 15(9):1143-1157. PubMed ID: 36415513
[TBL] [Abstract] [Full Text] [Related]
3. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract] [Full Text] [Related]
